Hidde Van Kerckhoven

Hidde Van Kerckhoven is a Vice President at Ampersand Capital Partners, a private equity firm that recently invested in Julius Clinical Research. He joined Ampersand in 2022 and has a background in healthcare investments, having previously worked with Gimv and The Riverside Company. At Ampersand, he focuses on supporting companies with established leadership positions in the pharmaceutical outsourcing market, emphasizing Julius Clinical's scientific expertise and growth potential.134

In the context of Julius Clinical, Van Kerckhoven highlighted that the investment aligns with Ampersand's strategy to enhance the company's capabilities in clinical trial services and expand its geographic reach in Europe and North America.24 His role involves leveraging his experience in healthcare investments to foster growth and development within the company.3